T2 Biosystems(TTOO) - 2024 Q2 - Quarterly Results
T2 Biosystems(TTOO)2024-07-29 21:00Exhibit 99.1 Total revenue for the second quarter of 2024 was $2.0 million, flat compared to the prior year period. Sepsis test revenue grew 27% compared to the prior year period, led by T2Bacteria® and T2Resistance® panel sales. The increased in sepsis test revenue was offset by declines in international instrument sales. T2 Biosystems Announces Second Quarter 2024 Financial Results Achieved record quarterly and first half sepsis test revenue, representing growth of 27% and 25% respectively compared to the ...